First Trust Health Care AlphaDEX Fund (FXH)
| Assets | $897.49M |
| Expense Ratio | 0.62% |
| PE Ratio | 17.07 |
| Shares Out | 8.70M |
| Dividend (ttm) | $0.34 |
| Dividend Yield | 0.34% |
| Ex-Dividend Date | Jun 26, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 5.78% |
| Volume | 24,332 |
| Open | 102.85 |
| Previous Close | 103.17 |
| Day's Range | 101.48 - 102.85 |
| 52-Week Low | 91.93 |
| 52-Week High | 114.38 |
| Beta | 0.75 |
| Holdings | 79 |
| Inception Date | May 8, 2007 |
About FXH
Fund Home PageThe First Trust Health Care AlphaDEX Fund (FXH) is an exchange-traded fund that is based on the StrataQuant Health Care index. The fund tracks a tiered, equal-weighted index of large- and mid-cap US health care companies. Holdings are selected and weighted based on various growth and value criteria. FXH was launched on May 8, 2007 and is issued by First Trust.
Top 10 Holdings
23.05% of assets| Name | Symbol | Weight |
|---|---|---|
| Biogen Inc. | BIIB | 2.36% |
| Exelixis, Inc. | EXEL | 2.33% |
| Regeneron Pharmaceuticals, Inc. | REGN | 2.32% |
| Jazz Pharmaceuticals plc | JAZZ | 2.30% |
| Avantor, Inc. | AVTR | 2.30% |
| Acadia Healthcare Company, Inc. | ACHC | 2.30% |
| Zimmer Biomet Holdings, Inc. | ZBH | 2.29% |
| Elanco Animal Health Incorporated | ELAN | 2.29% |
| United Therapeutics Corporation | UTHR | 2.28% |
| Merck & Co., Inc. | MRK | 2.28% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 26, 2025 | $0.0616 | Jun 30, 2025 |
| Mar 27, 2025 | $0.0669 | Mar 31, 2025 |
| Dec 13, 2024 | $0.0899 | Dec 31, 2024 |
| Sep 26, 2024 | $0.1263 | Sep 30, 2024 |
| Jun 27, 2024 | $0.109 | Jun 28, 2024 |
| Mar 21, 2024 | $0.1062 | Mar 28, 2024 |
Performance
FXH had a total return of -1.24% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.46%.
News
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US admini...
FXH: A Short-Term Tactical Health Care Play Worth Considering
FXH launched in May 2007 and has amassed $1.26 billion in assets under management. Its 0.62% expense ratio is significant, but its long-term returns are pretty solid. FXH trades at a 30% discount on f...
Biotech Innovations Remain At Forefront
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r...
Healthcare: A Wide Choice Of Large And Well-Established Companies
The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets...
Add Up The Pieces: The First Trust Health Care AlphaDEX Fund ETF Could Be Worth $85
For the First Trust Health Care AlphaDEX Fund ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $85.29 per unit.
Implied First Trust Health Care AlphaDEX Fund ETF Analyst Target Price: $85
For the First Trust Health Care AlphaDEX Fund ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $85.17 per unit.